ApprovalTrail

Approval · Notice of Compliance 7542 · 2005

SEROSTIM: Notice of Compliance 7542

Issued October 11, 2005

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
7542
Date
October 11, 2005
Product type
Biologic
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Other
Reason
Manufacturing changes and new presentation
Therapeutic class
Human growth hormone

Products in this notice

BrandDINStatus today
SEROSTIM02272075—

Medicinal ingredients